AstraZeneca’s New Antibody Treatment In Recent Trials Has Reduced The Risk Of Developing Coronary Symptoms By 77%. This Treatment Can Be Used For People Who Do Not Respond Well To Vaccination. AstraZeneca Antibody, According to the company,…